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To assess the contribution ofcardiovascular risk indicators to all-cause mortality, we us d data 
from a follow-up study conducted in the Netherlands since 1975. Of 6,057 participants aged 20 years 
or over at the start of the study, 9.5°/0 died during the 9 to 12 year follow-up period. Risk indicators 
independently related to all-cause mortality were age and diabetes mellitus in both sexes; pulse rate, 
smoking habits, antihypertensive drug use and a history of myocardial infarction most clearly in 
men; and body mass index and systolic blood pressure in women. A larger body mass index was 
associated with a gradual decrease in mortality probability. The risk of death for women in the 
highest quartile of body mass index (> 26.4 kg/m 2) relative to those in the lowest quartile (< 21.9 kg/ 
m0 was 0.56 (950/0 confidence limits 0.36 and 0.87). Serum cholesterol level showed no association 
with overall mortality. 
Risk functions were calculated to predict an individual's probability of dying within i 1.5 years as a 
function of the level of cardiovascular risk indicators. 
Our findings suggest that the major cardiovascular risk indicators, apart from affecting 
cardiovascular morbidity and mortality, also influence all-cause mortality. Consequently, favourable 
changes in these charateristics might lead to an increase in life expectancy. The maximum 
individual benefit o be expected from these changes may be stimated using the risk functions 
derived from our data. 
INTRODUCTION 
Many longitudinal studies have produced 
evidence for an association of certain risk indicators, 
e.g. blood pressure, smoking and serum cholesterol, 
with cardiovascular morbidity and mortality (1, 14, 15, 
26, 27, 34). In recent years more emphasis has been 
put on the contribution of these cardiovascular risk 
indicators in predicting death from all causes (18, 21, 
22, 24, 25). The latter approach offers certain 
advantages. The identification of risk indicators of all- 
Corresponding author. 
cause mortality would focus on preventive measures 
aimed at improving the primary health parameter of a 
population: life expectancy. Measures restricted to risk 
indicators of a specific disease category may 
simultaneously enhance the chance of developing 
another disease and hence have no effect on, or even 
be detrimental to survival. Moreover, individuals may 
be more interested in the impact of changes in their 
cardiovascular risk profile on survival, than on their 
chance of experiencing a specific event. 
Once identified, these risk indicators may be used 
to obtain risk functions that estimate the probability of 
occurrence of an event, in this case death, as function 
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of the level of the risk indicators (14). This approach 
not only enables estimation of an individual's 
probability of dying within a certain time span, but 
also allows calculation of the maximum benefit o be 
expected from risk factor intervention. 
We studied the contribution of cardiovascular risk 
indicators to all-cause mortality, using data from a 
large follow-up study conducted since the mid- 
seventies in the Netherlands. Further, risk functions 
predicting the 11.5 years probability of death were 
derived. 
MATERIALS AND METHODS 
Subjects 
Between 1975 and 1978 a study was initiated in 
Zoetermeer, a town with at that time 60,000 
inhabitants in the western part of the Netherlands 
(31). The objective was to study cardiovascular nd 
other chronic diseases and their determinants. All 
13,462 inhabitants aged 5 years or over of two districts 
were invited to participate. Only those above 20 years 
of age were included in the present analysis. The 
response in this age group was 75.6% (n = 6,547). 
At entry into the study the participants were 
interviewed by a physician, a venous blood sample 
and a urine sample was obtained, a self-administered 
questionnaire was checked, and a brief physical 
examination, including measurements of blood 
pressure pulse rate and body mass index, was 
performed. The cardiovascular risk indicators 
measured at baseline are given in Table 1. A detailed 
report on the methods applied has been published 
previously (31). Information on the vital status and 
migration of the participating inhabitants of 
Zoetermeer has been provided by the municipal 
authorities ince the start of follow-up. Until May 1st 
1987, the censor date, 490 members of the cohort 
(7.5%) were lost to follow-up due to migration, and 
because the dates of migration were unknown they were 
excluded from the analysis. The remaining 2,839 men 
and 3,218 women were included in the present study. 
Data analysis 
Because the follow-up period varied between the 
participants, the proportional hazards model was 
applied to assess the cardiovascular risk indicators 
measured at baseline that were determinants of all- 
cause mortality (Appendix) (2, 5). The proportionality 
assumption was checked using the log minus log 
survival function for the different variates (13). First, a 
bivariate analysis was performed, taking differences in 
age into account. Second, a multivariate model was 
applied in order to control for confounding. Only risk 
indicators that showed a clear association with 
mortality as indicated by the bivariate analysis (i.e., the 
coefficient/standard e ror _> 1.5), were included in the 
multivariate model. Identical models were used for 
men and women. 
TABLE 1. - Cardiovascular risk indicators measured at baseline. 
Risk indicator Measurement and/or units 
age 















weight/lenght 2 in kg/m 2 
mm Hg, mean of two consecutive measurements with a random zero 
sphygmomanometer (diastolic blood pressure based on Korotkoff 5) 
beats/minute 
mmol/1, method of Roesch-Lau 
mmol/1, method of Gochman and Schmitz 
mmol/l, Technicon method 
current smoking (yes/no) 
number of cigarettes/day smoked presently 
current coffee use (yes/no) 
number of cups/day used presently 
for the indication hypertension (yes/no) 
insulin or oral hypoglycemic drug use (yes/no) 
history of myocardial infarction (yes/no) 
history of stroke (yes/no) 
premenopausal/postmenopausal 
current use (yes/no) 
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To estimate an individual's probability of dying within 
a certain time span as a function of the level of the 
cardiovascular risk indicators, risk functions were 
obtained (Appendix). A risk indicator was included in 
the formula when it was a predictor of mortality in the 
multivariate analysis in either sex, i.e., a 95% 
confidence interval of the estimated relative risk not 
including 1.0. Separate risk functions were derived for 
men and women. The goodness of fit of the risk 
functions was checked computing the statistic C* g 
(Appendix) (17). 
RESULTS 
Determinants ofall-cause mortality 
The mean value or prevalence of the 
cardiovascular risk indicators measured at baseline are 
shown in Table 2. In the 9 to 12 year follow-up period 
10.8% of the men and 8.4% of the women died. 
Cardiovascular determinants showing an age- 
adjusted association with mortality were systolic blood 
pressure, diabetes mellitus and a history of myocardial 
infarction in both sexes; diastolic blood pressure, 
pulse rate, smoking habits, antihypertensive drug use 
and a history of stroke especially in men; and body 
mass index (BMI), serum creatinine and uric acid most 
pronounced in women. Serum cholesterol, coffee use, 
menopausal state and use of oral contraceptives were not 
related to all-cause mortality in the bivariate analysis. 
Because systolic blood pressure was a more powerful 
predictor of all-cause mortality than diastolic blood 
pressure, the former was included in the multivariate 
model. Of the two indicators for smoking habits, only 
the one reflecting current smoking (yes/no) was used. 
The results of the multivariate analyses are shown 
in Table 3. The relative risks (RR) represent estimates 
of mortality risk of the presence of a risk indicator 
relative to its absence, or of the increase in its level by 
the indicated magnitude. Multivariate analysis did not 
alter the main findings of the age-adjusted analysis in 
men. In women, the impact of serum creatinine, uric 
acid and a history of myocardial infarction on survival 
weakened. An increase in BMI, however, remained 
strongly and inversely related to mortality. 
In order to further investigate the apparent 
protective effect of an increasing BMI, the participants 
were categorized according to quartiles of BMI. The 
relative risk by quartiles of BMI is shown in Figure 1. A 
gradual risk reduction with increasing BMI is present 
in women only (test for trend in men: p > 0.10; test for 
trend in women: p < 0.05) (29). The risk of death for 
women in the highest quartile of BMI relative to those 
in the lowest quartile was 0.56 (95% confidence limits 
0.36 and 0.87). Smoking status had a clear effect on all- 
cause mortality in men only. To study the presence of 
a dose-response relationship, participants were 
categorized according to number of cigarettes smoked 
per day. A dose-response r lationship was present in 
men, but not in women (Fig. 2). 
TABLE 2. - Mean values and standard eviations (SD) or prevalence (%) of risk indicators measured atbaseline. 
men women 
Risk indicator n* mean (SD) n* mean (SD) 
or % or % 
age (years) 
body mass index (kg/m 2) 
systolic bp (mm Hg) 
diastolic bp (mm Hg) 
pulse rate (beats/min) 
serum cholesterol (mmol/1) 
serum uric acid (mmol/1) 
serum creatinine (pmol/l) 
current cigarette use 
cigarettes per day** 
current coffee use 






oral contraceptive use 
2839 45.1 (14.7) 3218 46.6 (16.0) 
2775 24.4 (2.9) 3167 24.4 (3.8) 
2782 132.1 (17.5) 3172 129.4 (20.8) 
2782 79.1 (11.9) 3172 78.4 (12.0) 
2779 75.8 (13.0) 3165 78.8 (13.3) 
2769 5.8 (1.1) 3154 5.8 (1.1) 
2767 0.3 (0.1) 3154 0.3 (0.1) 
2767 91.4 (15.7) 3154 77.8 (14.4) 
2773 52.7 % 3186 38.2 % 
1460 15.6 (8.2) 1214 11.4 (8.0) 
2832 97.7 % 3215 97.1% 
2832 5.2 (2.4) 3215 4.2 (2.1) 
2839 7.0 % 3218 16.2 % 
2718 1.1% 3120 1.2 % 
2835 3.1% 3213 1.6 % 
2835 0.6 % 3213 0.6 % 
. . . .  3198 39.9 % 
. . . .  3177 23.0 % 
* The numbers (n) given in the table correspond to the 
obtained. 
** Non-smokers excluded. 
bp = blood pressure. 
total number of men and women for whom data on a risk indicator were 
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TABLE 3. - Cardiovascular risk indicators and all-cause mortality. Relative risk (RR) and 950/0 confidence 
interval (95o/0 CI)*. 
men women 
Risk indicator (n = 2624)** (n = 3048)** 
RR (95% CI) RR (95% CI) 
age (per 5 years) 
body mass index (per 3 kg/m 2) 
systolic blood pressure (per 10 mmHg) 
pulse rate (per 10 beats/minute) 
serum uric acid (per 0.1 mmol/1) 
serum creatinine (per 20 lamol/1) 
current cigarette use (yes/no) 
antihypertensive drugs (yes/no) 
diabetes mellitus (yes/no) 
myocardial infarction (yes/no) 
stroke (yes/no) 
1 .61  (1.53-1.70) 1 .49  (1.41-1.58) 
0.92 (0.81-1.05) 0.88 (0.79-0.97) 
1 .04  (0.99-1.11) 1 .09  (1.02-1.15) 
1 .10  (1.01-1.20) 1 .02  (0.93-1.13) 
1.04 (0.88-1.22) 1 .17  (0.98-1.40) 
1.03  (0.89-1.20) 1 .11  (0.95-1.29) 
1 .55  (1.20-1.99) 0.89 (0.62-1.28) 
1 .42  (1.02-1,96) 1 .06  (0.78-1.42) 
1 .86  (1.08-3.19) 2.15 (1.21-3.82) 
1 .92  (1.30-2.83) 1.46 (0.90-2.36) 
1 .19  (0.51-2.74) 1 .39  (0.51-3.79) 
* Adjusted for differences in the other risk indicators. 
** The number of men and women corresponds to the number of subjects for whom all variables considered in the multivariate 
analysis were measured. 













fiR_+ 95% Ct 
3.5 
24.3-26.2 ,2e.2 men r~ l  11-20 m~ [~1 
23.9-26.4 ,26.4 women ~ womenlW~l 
body me~ t,~ex (l~l/m2) 
Figure 1. - Body mass index (BMI) and all-cause mortality in 
men and women. Relative risk (RR) and 95% confidence limits 
(95% CL)* of the four quartiles of BMI; the lowest quartile 
serves as a reference group (RR = 1). Adjusted for differences in 






0 0 1-I0 ,20 
number of olgenlttN amokKl per ~,y 
Figure 2. - Smoking habits and all-cause mortality in men and 
women. Relative risk (RR) and 950/0 confidence limits (95°/0 CL)* 
of the number of cigarettes smoked per day; non-smokers serve 
as the reference group (RR = 1). Adjusted for differences in the 
other risk indicators. 
Risk function 
Determinants hat were independently associated 
with overall mortality in either sex were included in 
the risk function. Risk functions predicting the 
probability of dying within 11.5 years were calculated 
(Appendix). The sex-specific coefficients of the 
cardiovascular risk indicators included in the risk 
functions are shown in Table 4. 
The expected and observed number of male 
survivors and deaths within 11.5 years, for each decile 
of mortality probability are given in Table 5. The 
goodness of fit statistic equals 6.8 (0.50 < p < 0.75). 
The value for the corresponding risk function in 
women is 14.9 (0.05 < p < 0.1). This indicates that the 
model has a moderate fit in women and that the risk 
function predicts mortality in men very accurately. 
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TABLE 4. - Cardiovascular risk indicators and all-cause mortality in men and women; coefficients (13) and 
standard errors (SE) of the risk indicators included in the risk function (multivariate analysis). 
13 SE 
Risk indicator women men women men 
age (years) 131 0.096 0.081 0.005 0.006 
body mass index (kg/m 2) 62 -0.033 -0.036 0.022 0.017 
systolic bp (mm Hg) 133 0.004 0.010 0.003 0.003 
pulse rate (beats/min) 134 0.009 0.001 0.004 0.010 
cigarette use 135 0.414 -0.119 0.129 0.186 
antihypertensive drugs 136 0.372 0.160 0.159 0,143 
diabetes mellitus 137 0.594 0.700 0.274 0.291 
myocardial infarction 138 0.672 0.436 0.193 0.246 
bp = blood pressure 
TABLE 5. - Goodness of fit of the risk function estimating the probability of dying within 11.5 years in men. 
Decile limits of risk number of deaths number of survivors 
% expected observed expected observed 
1 < 0.83 1.6 1 262.4 263 
2 0.83- 1.30 2.9 2 260.1 261 
3 1.31- 1.96 4.2 5 259.8 259 
4 1.97- 2.91 6.3 3 257.7 261 
5 2.92- 4.00 9.0 4 255.0 260 
6 4.01- 6.04 13.2 10 250.8 254 
7 6.05- 9.02 19.7 17 246.3 249 
8 9.03 - 14.95 30.2 32 232.8 231 
9 14.96 - 30.17 56.2 59 207.8 205 
10 > 30.17 140.5 141 124.5 124 
Total 283.8 274 2357.3 2367 
1 10 
C* g = Y' Y 
k=0 1=0 
(Okl - Ekl) 2 / Ekl = 6.83; 0.50 < p < 0.75 
DISCUSSION 
The primary objective of the present analysis was 
to assess the impact of cardiovascular risk indicators 
on all-cause mortality. The rationale for this approach 
is the possibility that certain preventive measures may, 
while having a beneficial effect on cardiovascular 
mortality, simultaneously increase mortality from 
other (non-cardiovascular) causes and hence, have no 
effect on or even decrease life expectancy. 
Alternatively, some measures could prove to be 
effective in preventing several chronic conditions at 
the same time. 
Most of the cardiovascular risk indicators that 
demonstrate an effect on overall mortality in the 
present analysis have been recognized in similar 
follow-up studies (6, 8, 11, 16, 18, 22, 23, 24, 25, 30). 
Nevertheless, ome of our findings warrant further 
elaboration and will be discussed below. 
The apparent "protective" effect of an increasing 
body mass index, especially in women, is a remarkable 
finding. In most other cohort studies either no effect 
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was reported, or a J- or U-shaped relationship between 
BMI and mortality was found (7, 9, 10, 21, 22, 23). 
When women were categorized according to quartiles 
of BMI a gradual decrease of the RR from 1.0, in the 
lowest BMI group, to 0.56 in the highest BMI group 
was present, without evidence of a J- or U-shaped 
curve. Several possible explanations of the inverse 
relationship between BMI and mortality were 
evaluated (21). Because hypertension, glucose 
intolerance and hyperlipidaemia h ve been reported 
to act as intermediate factors in the causal pathway 
through which obesity influences longevity, it could 
be argued that adjustment for these factors in 
multivariate analysis should be avoided when 
assessing the overall effect of BMI on mortality. As 
expected, exclusion of these "effects of obesity" from 
the model attenuated the inverse relationship between 
BMI and mortality, but the effect remained statistically 
significant. Also, exclusion of all participants with 
diabetes mellitus at the baseline xamination did not 
influence the association between body mass index 
and death from all causes. Further, a protective ffect 
of a larger BMI might result from excess mortality in 
the leanest subjects caused by an underlying 
condition, such as cancer, leading to weight loss and 
subsequently to premature death. Disregarding the 
first three years of follow-up, however, did not 
materially change the findings. Smoking status has 
been recognized as a strong confounder of the 
association between BMI and longevity (9). 
Adjustment for current smoking and the number of 
cigarettes moked daily did not alter the reported 
association. Yet, when smoking and non-smoking 
women were analyzed separately, the effect appeared 
to be restricted to smoking women only. From this 
analysis, residual confounding by smoking can not be 
excluded as an explanation for the inverse association. 
However, our findings clearly do not support an 
increase in risk with increasing body mass index. 
Therefore, the categorical labeling of overweight as 
unhealthy might prove to be unjustified when the 
outcome is longevity. 
No clear association between serum cholesterol 
level and all-cause mortality could be demonstrated, a 
finding similar to that in the Dutch male cohort of the 
Seven Countries Study (24), but at variance with some 
other large studies (22, 28). Moreover, no evidence 
was found of a J-shaped relationship between 
cholesterol level and mortality, nor could cholesterol 
be identified as a predictor of mortality within 
different age categories. Thus, contrary to the 
established role played by serum cholesterol in 
atherosclerotic vessel disease (3, 20), no similar 
importance for all-cause mortality could be detected 
in this study. This could be due to the size of our 
study, suggesting however that an effect, if present, is 
small. 
No association between smoking habits and 
mortality was found in women. This was unexpected, 
since cigarette smoking is a well-known predictor of 
cancer and cardiovascular mortality in both sexes. 
This phenomenon may result in part from a lower 
smoking rate in women than in men (11.4 and 15.6 
cigarettes/day respectively), but the absence of a dose- 
response relationship in women in contrast o men, 
remains unexplained. 
The second objective of this study was to obtain 
functions that predict an individual's probability of 
dying within a certain time period conditional on the 
risk profile. Since the Framingham cardiovascular risk 
function was published in 1976 (14), the use of such 
formulas has played a modest but increasing role in 
medical practice (1). Although the risk functions 
calculated from our study predict mortality 
satisfactory, as indicated by the goodness of fit 
statistic, the predictive value in men is better than in 
women. This might be explained in part by the lower 
mortality rate in women compared to men, leading to 
more accurate stimates of the coefficients in the 
latter group. 
Several limitations of our study need to be 
discussed. Ithas been suggested that selective response in
follow-up studies can lead to a relatively healthy 
cohort caused by an overrepresentation of participants 
at low risk. This selection bias seems to be limited in 
our study, since mortality rates among male and 
female participants (10.8 and 8.3/1000 person years, 
respectively) are similar to the age-adjusted rates in 
the Dutch population at large (11.8 and 7.4/1000 
person years, respectively) (4). Nevertheless, this effect 
could be diluted by a selective loss to follow-up of the 
healthy members of the cohort. Some evidence of the 
latter exists in that the cardiovascular risk profile of 
the 490 participants who were lost to follow-up due to 
migration was more beneficial than that of the 
remaining members, as indicated by a lower mean age 
(35.2 years in men, 37.0 years in women) and a lower 
systolic blood pressure (130.3 mm Hg in men, 124.6 
mm Hg in women). To further study the 
representativeness of our study population, the 
prevalence of the major cardiovascular risk indicators 
in our sample was compared with the prevalence 
reported in other studies performed in the 
Netherlands. The reported prevalence of most risk 
indicators, e.g. diabetes mellitus, hypertension and 
smoking, was similar to our findings (31, 32). 
All risk indicators were measured only once at the 
start of the study. Hence, changes in the risk profile 
within the follow-up period could not be taken into 
account (12). 
Finally, it must be stressed that the results of an 
analysis of determinants of all-cause mortality can 
only be applied to populations with similar patterns of 
causes of death. The causes of death among the 576 
participants who died during the follow-up period 
were comparable tothe causes of death recorded in all 
of the Netherlands from 1980 to 1984. For example, 
cardiovascular diseases accounted for 42% of all 
deaths in our cohort, while the corresponding 
proportion for the Netherlands was 43% (19). 
In summary, our findings suggest that the major 
cardiovascular isk indicators not only affect 
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cardiovascular morbid i ty and mortality, but also 
inf luence survival irrespective o f  cause o f  death. By 
inference, favourable changes in these characteristics 
might lead to increase in life expectancy. The 
max imum individual benefit  to be expected from 
these changes can be est imated using the risk 
functions derived from our data. 
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APPENDIX 
The proportional hazards model is based on the hazard 
function: 
h (t,z) = Ao(t). exp(Bl.zl + B2.z2 +... Bp.zp). 
The corresponding survival function is given by: 
S(t,z) = S0(t) exp~tzl + 62z2 .... ~ozp) 
These formulas describe the hazard rate A(t,z) or probability of 
survival S(t,z) as being dependent on the basic hazard rate A0(t) 
or basic survival function S0(t) respectively, and on a risk 
indicator function (81.zl +...13p.zp). The coefficients 131 to 8p 
are estimated by the computer program (2), and zl to zp are an 
individual's level of the risk factors. The basic hazard rate and 
survival function correspond to the incidence rate and the 
survival probability for individuals with (extrapolated) levels of 
the risk indicators of zero, and thus only changes with time 
elapsed since the start of the follow-up period. 
A risk function takes the following form in the proportional 
hazards model: 
P(t) = 1 - S(t,z) = 1 - S0(t) °xp(Bl"zl + ~2.z2 .... Bpzp) 
P(t) indicates the probability of an event within a certain period 
and equals 1 - S(t,z). The formula includes a time-dependent 
variate S0(t), which is not provided by the standard computer 
programs applying the model. In the present analysis the values 
of S0(t) were calculated indirectly using an option in the BMD 
P2L program which gives a table containing the survival 
probability as a function of time for the mean vector, i.e., an 
individual with all risk indicators equal to the population mean 
(2). 
The goodness of fit of the risk function can be assessed by 
computing the statistical characteristic C* g as proposed by 
Lemeshow and Hosmer (17): 
1 10 
C* g = E E (Okl " Ekl) 2 / Ekl 
k=0 1=0 
where Ok1 and Ek~ are the observed and expected number of 
deaths in the twenty cells formed by the deciles of risk (1 from 1 
to 10) for those with (k = 1) or without (k = 0) the end-point at 
interest. The distribution of the statistic is closely approximated 
by a chi-square distribution with (1 minus 2) degrees of freedom. 
The probability of dying within 11.5 years, the maximum follow- 
up period, for men equals: 1 - 0.99968 exp(r~sk ..... ). 
The probability of dying within 11.5 years for women equals: 
1 - 0.99945 ~xp(~i~k . . . . .  ) 
The individual risk scores in the formulas can be computed 
using the sex-specific coefficients (131, 132,...138) in Table 4 and 
the actual evel of the risk indicators in the following formula: 
risk score = B1. age + B2. body mass index + B3. systolic blood 
~ressure +134. pulse rate + 135. cigarette use (yes = 1, no = 0) + 
6. antihypertensive drug use (yes = 1, no = 0) + 137. diabetes 
(yes = 1, no = 0) + B8. myocardial infarction (yes = 1, no = 0). 
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